Pembrolizumab Alone or With Chemotherapy Prolongs OS in Recurrent/Metastatic HNSCC

Pembrolizumab monotherapy and pembrolizumab plus chemotherapy prolonged OS in recurrent/metastatic HNSCC.

from Latest articles from Cancer Therapy Advisor News https://ift.tt/2OHlNyz